NuVasive Inc.

56.96-1.50-2.57%Vol 692.77K1Y Perf -28.55%
Jan 15th, 2021 16:00 DELAYED
BID55.38 ASK58.49
Open58.04 Previous Close58.46
Pre-Market- After-Market-
 - -%  - -
Target Price
59.53 
Analyst Rating
Moderate Buy 2.36
Potential %
4.51 
Finscreener Ranking
★★★     50.93
Insiders Trans % 3/6/12 mo.
100/100/-50 
Value Ranking
★★     46.19
Insiders Value % 3/6/12 mo.
100/100/-75 
Growth Ranking
★★     45.16
Insiders Shares Cnt. % 3/6/12 mo.
100/100/-64 
Income Ranking
 —    -
Market Cap2.92B 
Earnings Rating
Neutral
Price Range Ratio 52W %
54.17 
Earnings Date
18th Feb 2021

Today's Price Range

56.4158.68

52W Range

28.5581.00

5 Year PE Ratio Range

-112.20354.50

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
3.80%
1 Month
27.45%
3 Months
9.96%
6 Months
-2.27%
1 Year
-28.55%
3 Years
9.62%
5 Years
19.09%
10 Years
109.01%

TickerPriceChg.Chg.%
NUVA56.96-1.5000-2.57
AAPL127.14-1.7700-1.37
GOOG1 736.19-3.9900-0.23
MSFT212.65-0.3700-0.17
XOM47.89-2.4200-4.81
WFC32.04-2.7100-7.80
JNJ160.30-0.3500-0.22
FB251.365.72002.33
GE11.33-0.3300-2.83
JPM138.64-2.5300-1.79
Financial StrengthValueIndustryS&P 500US Markets
1.40
1.90
0.49
1.69
0.70
Leverage Ratio 2.80
ProfitabilityValueIndustryS&P 500US Markets
70.00
4.10
17.20
5.70
-5.12
RevenueValueIndustryS&P 500US Markets
758.78M
14.80
-5.46
2.49
Earnings HistoryEstimateReportedSurprise %
Q03 20200.270.54100.00
Q02 2020-0.49-0.4018.37
Q01 20200.350.4837.14
Q04 20190.630.7315.87
Q03 20190.540.599.26
Q02 20190.560.6312.50
Q01 20190.410.5329.27
Q04 20180.630.699.52
Earnings Per EndEstimateRevision %Trend
12/2020 QR0.58-4.92Negative
12/2020 FY1.2127.37Positive
3/2021 QR0.44-13.73Negative
12/2021 FY2.35-5.24Negative
Next Report Date18th Feb 2021
Estimated EPS Next Report0.57
Estimates Count10
EPS Growth Next 5 Years %13.40
Volume Overview
Volume692.77K
Shares Outstanding51.28M
Trades Count3.46K
Dollar Volume44.40M
Avg. Volume1.03M
Avg. Weekly Volume765.09K
Avg. Monthly Volume930.53K
Avg. Quarterly Volume905.73K

NuVasive Inc. (NASDAQ: NUVA) stock closed at 58.46 per share at the end of the most recent trading day (a 4.06% change compared to the prior day closing price) with a volume of 1.01M shares and market capitalization of 2.92B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 2600 people. NuVasive Inc. CEO is .

The one-year performance of NuVasive Inc. stock is -28.55%, while year-to-date (YTD) performance is 3.78%. NUVA stock has a five-year performance of 19.09%. Its 52-week range is between 28.55 and 81, which gives NUVA stock a 52-week price range ratio of 54.17%

NuVasive Inc. currently has a PE ratio of -268.20, a price-to-book (PB) ratio of 3.21, a price-to-sale (PS) ratio of 3.85, a price to cashflow ratio of 15.70, a PEG ratio of 2.32, a ROA of -0.39%, a ROC of 1.64% and a ROE of -0.97%. The company’s profit margin is -5.12%, its EBITDA margin is 17.20%, and its revenue ttm is $758.77 Million , which makes it $14.80 revenue per share.

Of the last four earnings reports from NuVasive Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.57 for the next earnings report. NuVasive Inc.’s next earnings report date is 18th Feb 2021.

The consensus rating of Wall Street analysts for NuVasive Inc. is Moderate Buy (2.36), with a target price of $59.53, which is +4.51% compared to the current price. The earnings rating for NuVasive Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

NuVasive Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

NuVasive Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 35.00, ATR14 : 5.87, CCI20 : 69.33, Chaikin Money Flow : 478.04, MACD : 2.06, Money Flow Index : 56.68, ROC : 6.64, RSI : 62.26, STOCH (14,3) : 95.31, STOCH RSI : 0.41, UO : 85.64, Williams %R : -4.69), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of NuVasive Inc. in the last 12-months were: Gregory T. Lucier (Option Excercise at a value of $0), James Christopher Barry (Option Excercise at a value of $0), Lucas Vitale (Option Excercise at a value of $0), Matthew Link (Option Excercise at a value of $0), Matthew Link (Sold 9 000 shares of value $679 800 ), Nathaniel Sisitsky (Option Excercise at a value of $0), Vickie L. Capps (Buy at a value of $96 460)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (42.86 %)
6 (42.86 %)
4 (33.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
6 (42.86 %)
6 (42.86 %)
7 (58.33 %)
Moderate Sell
1 (7.14 %)
1 (7.14 %)
1 (8.33 %)
Strong Sell
1 (7.14 %)
1 (7.14 %)
0 (0.00 %)
Summary RatingModerate Buy
2.36
Moderate Buy
2.36
Moderate Buy
2.42

NuVasive Inc.

NuVasive Inc is a medical-device company focused on minimally invasive surgical products and integrated solutions for spine surgery. The firm's spine surgery products contribute the majority of revenue. Its key offering is the maximum access surgery minimally disruptive surgical platform, which minimizes soft-tissue disruption and contact with critical nerves and maximizes visualization during spine fusion surgery. NuVasive also develops biologics used to aid in the spinal fusion or bone-healing processes, such as a collagen-based synthetic bone substitute and synthetic bone-graft material. NuVasive generates the majority of its revenue in the United States.

CEO:

Teplephone: +1 858 909-1800

Address: 7475 Lusk Boulevard, San Diego 92121, CA, USA

Number of employees: 2 600

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

52%48%

Bearish Bullish

60%40%

News

Stocktwits